within Pharmacolibrary.Drugs.ATC.S;

model S01GA05
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.018333333333333333,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01GA05</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Phenylephrine is a selective alpha-1 adrenergic receptor agonist that is used primarily as a decongestant, to increase blood pressure in hypotensive states, and as a mydriatic agent in ophthalmology. The S01GA05 ATC code refers to its ophthalmic use to induce mydriasis and reduce redness in the eye. It is approved and commonly used today in eye drops for diagnostic and therapeutic ocular procedures.</p><h4>Pharmacokinetics</h4><p>Estimated PK parameters for topical ophthalmic administration in healthy adults, as available published sources do not describe systemic pharmacokinetic modeling following ophthalmic use.</p><h4>References</h4><ol><li><p>Antoine, ME, et al., &amp; O&#x27;Brien, WJ (1984). Pharmacokinetics of topical ocular phenylephrine HCl. <i>Investigative ophthalmology &amp; visual science</i> 25(1) 48–54. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6698730/&quot;>https://pubmed.ncbi.nlm.nih.gov/6698730</a></p></li><li><p>Chien, DS, &amp; Schoenwald, RD (1990). Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes. <i>Pharmaceutical research</i> 7(5) 476–483. DOI:<a href=&quot;https://doi.org/10.1023/a:1015808514727&quot;>10.1023/a:1015808514727</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2367315/&quot;>https://pubmed.ncbi.nlm.nih.gov/2367315</a></p></li><li><p>Hendeles, L (1993). Selecting a decongestant. <i>Pharmacotherapy</i> 13(6 Pt 2) 129S–146S. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7507590/&quot;>https://pubmed.ncbi.nlm.nih.gov/7507590</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01GA05;
